Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs

N Moore, C Pollack, P Butkerait - Therapeutics and clinical risk …, 2015 - Taylor & Francis
Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen have a long history of safe
and effective use as both prescription and over-the-counter (OTC) analgesics/antipyretics …

[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research …

W Zhang, G Nuki, RW Moskowitz, S Abramson… - Osteoarthritis and …, 2010 - Elsevier
OBJECTIVE: To update evidence for available therapies in the treatment of hip and knee
osteoarthritis (OA) and to examine whether research evidence has changed from 31 …

[图书][B] Deadly medicines and organised crime: how big pharma has corrupted healthcare

P Gotzsche - 2019 - taylorfrancis.com
PRESCRIPTION DRUGS ARE THE THIRD LEADING CAUSE OF DEATH AFTER HEART
DISEASE AND CANCER. In his latest ground-breaking book, Peter C Gotzsche exposes the …

[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines

W Zhang, RW Moskowitz, G Nuki, S Abramson… - Osteoarthritis and …, 2008 - Elsevier
PURPOSE: To develop concise, patient-focussed, up to date, evidence-based, expert
consensus recommendations for the management of hip and knee osteoarthritis (OA), which …

Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies

P McGettigan, D Henry - PLoS medicine, 2011 - journals.plos.org
Background Randomised trials have highlighted the cardiovascular risks of non-steroidal
anti-inflammatory drugs (NSAIDs) in high doses and sometimes atypical settings. Here, we …

Pharmacological management of persistent pain in older persons

American Geriatrics Society Panel on the … - Pain …, 2009 - academic.oup.com
Pain is a complex phenomenon caused by noxious sensory stimuli or neuropathological
mechanisms. An individual's memories, expectations, and emotions modify the experience …

Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and …

C Scarpignato, A Lanas, C Blandizzi, WF Lems… - BMC medicine, 2015 - Springer
Background There are several guidelines addressing the issues around the use of NSAIDs.
However, none has specifically addressed the upper versus lower gastrointestinal (GI) risk …

[HTML][HTML] OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of …

W Zhang, RW Moskowitz, G Nuki, S Abramson… - Osteoarthritis and …, 2007 - Elsevier
PURPOSE: As a prelude to developing updated, evidence-based, international consensus
recommendations for the management of hip and knee osteoarthritis (OA), the Osteoarthritis …

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2

P McGettigan, D Henry - Jama, 2006 - jamanetwork.com
ContextEvidence that rofecoxib increases the risk of myocardial infarction has led to scrutiny
of other nonsteroidal anti-inflammatory drugs (NSAIDs). Regulatory agencies have provided …

Hypertension in rheumatoid arthritis

VF Panoulas, GS Metsios, AV Pace, H John… - …, 2008 - academic.oup.com
RA associates with an increased burden of cardiovascular disease, which is at least partially
attributed to classical risk factors such as hypertension (HT) and dyslipidaemia. HT is highly …